MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 571 trials for IBD
IBD Strong Peer2Peer for Self-Management of Psychological DistressRecruiting
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Psychological distress (PD) as a result of inflammatory bowel disease (IBD) is prevalent and associated with worse disea…
Halifax, CanadaEst. completion Mar 2027
View Trial →
Confirmatory Clinical Study in Active Ulcerative ColitisPhase 2Recruiting
Colitis, Ulcerative
The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcera…
Miami, United StatesEst. completion Sep 2027
View Trial →
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative ColitisPhase 1Recruiting
Ulcerative Colitis (UC)
A study to investigate the safety, tolerability, and pharmacokinetics (PK) of ONO-6414 orally in healthy adult participa…
Miami, United StatesEst. completion Dec 31, 2027
View Trial →
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)Phase 2Recruiting
Colitis UlcerativeUlcerative Colitis
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active u…
Anaheim, United StatesEst. completion Oct 28, 2027
View Trial →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Phase 3Recruiting
Crohn DiseaseColitis, Ulcerative
Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medic…
Bristol, United StatesEst. completion Dec 17, 2037
View Trial →
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseasePhase 4Recruiting
Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with ada…
Dothan, United StatesEst. completion Jun 28, 2027
View Trial →
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's DiseaseRecruiting
Crohn's Disease
The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose…
Esbjerg, DenmarkEst. completion Aug 31, 2027
View Trial →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Phase 3Recruiting
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
View Trial →
Clinical and Basic Investigations Into Hermansky-Pudlak SyndromeRecruiting
Hermansky-Pudlak Syndrome (HPS)
Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism…
Bethesda, United States
View Trial →
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Phase 2Recruiting
Ulcerative Colitis
The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compa…
Scottsdale, United StatesEst. completion May 2027
View Trial →
Standardized Microbiota Transplant Therapy in Crohn's DiseasePhase 2Recruiting
Crohn Disease
Crohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune syst…
Minneapolis, United StatesEst. completion Jun 15, 2029
View Trial →
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationPhase 4Recruiting
LactationInflammatory Bowel Disease
The main purpose of this study is to assess the amount of mirikizumab in breast milk in women who are breastfeeding who …
Glenview, United StatesEst. completion Sep 2028
View Trial →
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's DiseasePhase 2Recruiting
Crohn Disease
The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089)…
Scottsdale, United StatesEst. completion Jun 2027
View Trial →
LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisPhase 2Recruiting
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adul…
Phoenix, United StatesEst. completion Jun 2030
View Trial →
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseasePhase 2Recruiting
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027
View Trial →
Clostridium Butyricum in Stenosing Crohn's DiseasePhase 1Recruiting
Crohn Disease (CD)
Crohn's disease is a condition of unknown etiology with an immune-mediated pathogenesis. The subgroup of Crohn's disease…
Roma, ItalyEst. completion Dec 31, 2026
View Trial →
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyPhase 3Recruiting
Ulcerative ColitisObesity or Overweight
The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide,…
Dothan, United StatesEst. completion Apr 2028
View Trial →
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseasePhase 2Recruiting
Inflammatory Bowel DiseasesCrohn's Disease
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety o…
Lancaster, United StatesEst. completion Sep 2028
View Trial →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisPhase 3Recruiting
Ulcerative Colitis
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of…
Phoenix, United StatesEst. completion Jul 2034
View Trial →
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightPhase 3Recruiting
Crohn's DiseaseObesity or Overweight
The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizum…
Dothan, United StatesEst. completion May 2028
View Trial →
← PreviousPage 1 of 29Next →
Recruitment Status